Total Valuation
Resmed has a market cap or net worth of $607.54B. The enterprise value is $31.29B.
Market Cap$607.54B
Enterprise Value$31.29B
Share Statistics
Resmed has 140,639,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding140,639,240
Owned by Insiders0.55%
Owned by Institutions2.42%
Financial Efficiency
Resmed’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 19.27%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)19.27%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee497.22K
Profits Per Employee133.97K
Employee Count11,370
Asset Turnover0.63
Inventory Turnover2.33
Valuation Ratios
The current PE Ratio of Resmed is 20.9. Resmed’s PEG ratio is 2.00.
PE Ratio20.9
PS Ratio4.99
PB Ratio4.28
Price to FCF17.10
Price to Operating Cash Flow10.53
PEG Ratio2.00
Income Statement
In the last 12 months, Resmed had revenue of 5.65B and earned 1.52B in profits. Earnings per share was 10.44.
Revenue5.65B
Gross Profit3.45B
Operating Income1.91B
Pretax Income1.92B
Net Income1.52B
EBITDA2.15B
Earnings Per Share (EPS)10.44
Cash Flow
In the last 12 months, operating cash flow was 3.12B and capital expenditures -273.23M, giving a free cash flow of 2.85B billion.
Operating Cash Flow3.12B
Free Cash Flow2.85B
Free Cash Flow per Share20.26
Dividends & Yields
Resmed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.02
52-Week Price Change5.99%
50-Day Moving Average4.04K
200-Day Moving Average3.94K
Relative Strength Index (RSI)94.82
Average Volume (3m)10.00
Important Dates
Resmed upcoming earnings date is Jan 28, 2027, After Close (Confirmed).
Last Earnings DateOct 29, 2026
Next Earnings DateJan 28, 2027
Ex-Dividend Date―
Financial Position
Resmed as a current ratio of 3.10, with Debt / Equity ratio of 10.27%
Current Ratio3.10
Quick Ratio2.42
Debt to Market Cap0.02
Net Debt to EBITDA-0.30
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Resmed has paid 396.12M in taxes.
Income Tax396.12M
Effective Tax Rate0.21
Enterprise Valuation
Resmed EV to EBITDA ratio is 12.80, with an EV/FCF ratio of 16.71.
EV to Sales4.87
EV to EBITDA12.80
EV to Free Cash Flow16.71
EV to Operating Cash Flow15.26
Balance Sheet
Resmed has $1.01B in cash and marketable securities with $610.58M in debt, giving a net cash position of $400.16M billion.
Cash & Marketable Securities$1.01B
Total Debt$610.58M
Net Cash$400.16M
Net Cash Per Share$2.85
Tangible Book Value Per Share$22.27
Margins
Gross margin is 61.18%, with operating margin of 33.76%, and net profit margin of 26.94%.
Gross Margin61.18%
Operating Margin33.76%
Pretax Margin33.95%
Net Profit Margin26.94%
EBITDA Margin38.08%
EBIT Margin33.76%
Analyst Forecast
The average price target for Resmed is $4,917.01, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4,917.01
Price Target Upside28.01% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast-2.19%
EPS Growth Forecast0.56%